h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
PUMCHi003-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
PUMCHi003-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
PUMCHi003-A (RRID:CVCL_ZL87)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
22nd April 2022
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Peking Union Medical College Hospital (PUMCH)
Contact:
Peking Union Medical College Hospital (PUMCH)
Owner
Peking Union Medical College Hospital (PUMCH)
Distributors
Peking Union Medical College Hospital (PUMCH)
External Databases
BioSamples
SAMEA6983565
Cellosaurus
CVCL_ZL87
Wikidata
Q98128717
General Information
Publications
Zhang SJ et al. Derivation of an induced pluripotent stem cell line (PUMCHi003-A) from a patient with pulmonary arterial hypertension carrying heterozygous mutation in PTGIS gene. Stem cell research. 2020 Jul;46:101875.
Zhu YJ et al. Generation of an induced pluripotent stem cell line (PUMCHi006-A) derived from a patient with pulmonary arterial hypertension carrying heterozygous c.1339 G > A mutation in PTGIS gene. Stem cell research. 2020 Dec;49:102088.
Lian TY et al. Building a modern six-dimensional biobank fosters the future of precision medicine. Science bulletin. 2022 Dec 31;67(24):2490-2493.
Zheng Ruixuan et al. Stem cell therapy in pulmonary hypertension: current practice and future opportunities. European Respiratory Review. 2023-09-30.
* Is the cell line readily obtainable for third parties?
Yes
Research use:
allowed
Clinical use:
not allowed
Commercial use:
allowed
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.